K

KBI Biopharma

CDMO delivering cell line development

Associate Scientist / Scientist 1

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeBoulder, CO, USAIn-person

About the Job

Requirements

  • For Associate Scientist, a bachelor's degree in a related field and at least 5 years of experience, or a master's degree and at least 3 years of experience, is required.
  • For Scientist I, a bachelor's degree in a related field and at least 6 years of experience, a master's degree and at least 5 years of experience, or a PhD and at least 0 years of experience, is required.
  • Good written and verbal communication skills are required.
  • Critical thinking and scientific skills, including the ability to analyze, interpret, and clearly present complex data with conclusions, are required.

Responsibilities

  • Support in-process testing for the manufacturing of biopharmaceutical products.
  • Perform current Good Manufacturing Practice (cGMP) testing on product release and stability programs.
  • Perform stability trending and support troubleshooting and laboratory investigations.
  • Exercise technical discretion in executing and interpreting experiments that contribute to project goals.
  • Ensure accurate and complete documentation of results using electronic notebooks, technical documents, presentations, and related materials.
  • Support the review and approval of analytical test methods, study protocols, and technical reports.
  • Adhere to safety requirements and ensure departmental employees comply with required safety procedures.
  • Adapt productively to change and handle other essential tasks as assigned.

Desired Qualifications

  • Experience with current Good Manufacturing Practice (cGMP) and regulations for biotechnology-derived products is a plus.

About the Company

KBI Biopharma

CDMO delivering cell line development

KBI Biopharma is a CDMO that accelerates the development of biological medicines by providing rapid cell line generation and process development for preclinical programs. It uses established mammalian and microbial expression systems (such as CHO K1, CHO S, CHO DG44, HEK293, and DXB11 E. coli) to create production cell lines and develop integrated manufacturing processes. Compared with competitors, it wins on speed, end-to-end capability, and flexibility across multiple platforms to move projects quickly from discovery to preclinical milestones for a diverse client base. Its goal is to reduce risk, shorten development timelines, and expand global access to life-saving biologic therapies.

Company size
1,001-5,000
Company stage
Late Stage VC
Total funding
$109.5M
Headquarters
Durham, NC
Founded
1996

Recently Posted Jobs

Explore more opportunities at KBI Biopharma

See more jobs